Stocks and Investing
Stocks and Investing
Tue, May 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, May 8, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Matthew Biegler Reiterated (TYRA) at Buy and Held Target at $25 on, May 8th, 2023
Matthew Biegler of Oppenheimer, Reiterated "Tyra Biosciences, Inc." (TYRA) at Buy and Held Target at $25 on, May 8th, 2023.
Matthew has made no other calls on TYRA in the last 4 months.
There is 1 other peer that has a rating on TYRA. Out of the 1 peers that are also analyzing TYRA, 0 agree with Matthew's Rating of Hold.
This is the rating of the analyst that currently disagrees with Matthew
- Mitchell Kapoor of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $17 on, Friday, May 5th, 2023
Contributing Sources